Middle East & Africa Anatomic Pathology Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The anatomic pathology market size is expected to reach US$ 1,183.18 million by 2031 from US$ 740.39 million in 2023. The market is estimated to record a CAGR of 6.0% from 2023 to 2031.

Executive Summary and Middle East & Africa Anatomic Pathology Market Analysis:

The anatomic pathology market in the Middle East & Africa has been analyzed on the basis of the market performance in Saudi Arabia, the UAE, South Africa, and the Rest of the Middle East & Africa. The Middle East is currently experiencing a rise in the incidence of chronic diseases such as strokes, neurological disorders, and cancer, along with a continuous surge in the geriatric population. Moreover, the high acceptance and installation of modern diagnostic technologies are projected to drive the anatomic pathology market growth in this region in the coming years.

Middle East & Africa Anatomic Pathology Market Strategic Insights

Get more information on this report Request Free Sample PDF

Middle East & Africa Anatomic Pathology Market Segmentation Analysis

Key segments that contributed to the derivation of the anatomic pathology market analysis are product and services, application, and end user.

• Based on product and services, the Middle East & Africa anatomic pathology market is segmented into services, instruments, and consumables. The instruments held the largest share of the market in 2023. The services segment is further sub segmented into histopathology and cytopathology. The instruments segment is further sub segmented into microtomes and cryostat, automatic stainer's, tissue processors, and others.
• By application, the Middle East & Africa anatomic pathology market is segmented into disease diagnosis, drug discovery and development and others. The disease diagnosis segment held the largest share of the market in 2023.
• By end user, the Middle East & Africa anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2023.

Middle East & Africa Anatomic Pathology Market Outlook

Personalized medicines are mainly designed by considering individuals' genetic profiles to guide the decisions made with respect to the prevention, diagnosis, and treatment of a disease. They provide an opportunity for drug manufacturers to develop agents that target patient groups that do not respond to medications as intended or for them who do not respond as expected to traditional healthcare practices. There is much evidence indicating that a substantial portion of the variability in drug response depends on factors that are genetically controlled, including age, nutrition, environmental exposure, and health status. Genomics plays an important role in the emergence of personalized medicines, as having the knowledge of a patient's genetic profile would help doctors in selecting an apt medication. Personalized medicines are helpful in improving healthcare by enabling each patient to receive earlier diagnoses, risk assessments, and optimal treatments.

Pathologists play an important role in developing and implementing molecular and genomic tests in practice. Personalized medicines are used in the treatment of diseases such as breast cancer and cardiovascular diseases. Personalized anticancer medicines exhibit fewer and less severe side effects than other types of treatment as they are designed for more specific action. Further, with the ongoing progress in research and clinical studies, personalized medicines are likely to reach even greater potential to improve the quality of patient care. Thus, the growing focus on personalized medicines is expected to boost the anatomic pathology market growth.

Middle East & Africa Anatomic Pathology Market Country Insights

Based on country, the Middle East & Africa anatomic pathology market comprises South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa held the largest share in 2023.

According to Health24, cancer cases in South Africa are estimated to surge by ~75%, reaching ~22.2 million by 2030 from 12.7 million in 2008. As per the Cancer Association of South Africa (CANSA), ~100,000 South Africans are diagnosed with cancer every year. With the growing number of cancer cases, the demand for advanced diagnostic tests is on the rise in the country. Further, the medical research authorities in South Africa are focusing on strategic initiatives to boost the adoption of diagnostic technologies. In December 2023, researchers at the Mary Heersink Institute for Global Health (MHIGH) utilized forensic pathology to study tuberculosis (TB) through a collaborative effort between UAB and the Africa Health Research Institute (AHRI) in Durban, South Africa. The MHIGH initiated a pilot project grant to facilitate collaboration and provide resources to UAB researchers and their global partners, aiming to address critical global health issues. The presence of prominent research laboratories and institutions such as JDW Pathology; Drs Gritzman & Thatcher Incorporated; and the College of Pathologists of East, Central and Southern Africa (COPECSA) significantly contribute to research that advances the anatomic pathology market in South Africa.

Middle East & Africa Anatomic Pathology Market Report Highlights

Middle East & Africa Anatomic Pathology Market Company Profiles

Some of the key players operating in the market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Anatomic Pathology Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insight Partners’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Middle East & Africa Anatomic Pathology Market Country and Regional Insights